Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Paulzen

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
The Pharmacogenomics Journal|June 2, 2020
Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer statusArnim Johannes Gaebler, Katharina Luise Schneider, Julia Carolin Stingl, et al.
Journal of Affective Disorders|January 28, 2017
Sertraline in pregnancy - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord bloodMichael Paulzen, Tamme W Goecke, Elmar Stickeler, et al.
Therapeutic Drug Monitoring|May 9, 2025
Nifedipine May Be an Inhibitor of Clozapine Metabolism as Seen in 5 Patients: 2 From a US Double-Blind Study and 3 From a German Therapeutic Drug Monitoring StudyGeorgios Schoretsanitis, Ekkehard Haen, Hélène Verdoux, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 28, 2018
Reduced clearance of venlafaxine in a combined treatment with quetiapineMichael Paulzen, Georgios Schoretsanitis, Christoph Hiemke, et al.
Patient Preference and Adherence|April 17, 2025
Identification and Rating of Treatment Goals in Schizophrenia: Delphi Process and Concordance Survey in Matched Physician-Patient PairsGerhard Gründer, Philipp Bauknecht, Stefanie Schell, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2022
Drug-drug interactions between psychotropic medications and oral contraceptivesGeorgios Schoretsanitis, Kristina M Deligiannidis, Michael Paulzen, et al.
Therapeutic Drug Monitoring|August 20, 2019
Excretion of Antipsychotics Into the Amniotic Fluid, Umbilical Cord Blood, and Breast Milk: A Systematic Critical Review and Combined AnalysisGeorgios Schoretsanitis, Andreas A Westin, Kristina M Deligiannidis, et al.
Archives of Women'S Mental Health|August 18, 2018
Antidepressants in breast milk; comparative analysis of excretion ratiosGeorgios Schoretsanitis, Marc Augustin, Helena Saßmannshausen, et al.
Schizophrenia Research|June 12, 2019
Effect of fluvoxamine augmentation and smoking on clozapine serum concentrationsMarc Augustin, Georgios Schoretsanitis, Philippe Pfeifer, et al.
The Journal of Clinical Psychiatry|September 8, 2018
Differences in Duloxetine Dosing Strategies in Smoking and Nonsmoking Patients: Therapeutic Drug Monitoring Uncovers the Impact on Drug MetabolismMarc Augustin, Georgios Schoretsanitis, Christoph Hiemke, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
The Pharmacogenomics Journal|June 2, 2020
Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer statusArnim Johannes Gaebler, Katharina Luise Schneider, Julia Carolin Stingl, et al.
Journal of Affective Disorders|January 28, 2017
Sertraline in pregnancy - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord bloodMichael Paulzen, Tamme W Goecke, Elmar Stickeler, et al.
Therapeutic Drug Monitoring|May 9, 2025
Nifedipine May Be an Inhibitor of Clozapine Metabolism as Seen in 5 Patients: 2 From a US Double-Blind Study and 3 From a German Therapeutic Drug Monitoring StudyGeorgios Schoretsanitis, Ekkehard Haen, Hélène Verdoux, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 28, 2018
Reduced clearance of venlafaxine in a combined treatment with quetiapineMichael Paulzen, Georgios Schoretsanitis, Christoph Hiemke, et al.
Patient Preference and Adherence|April 17, 2025
Identification and Rating of Treatment Goals in Schizophrenia: Delphi Process and Concordance Survey in Matched Physician-Patient PairsGerhard Gründer, Philipp Bauknecht, Stefanie Schell, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2022
Drug-drug interactions between psychotropic medications and oral contraceptivesGeorgios Schoretsanitis, Kristina M Deligiannidis, Michael Paulzen, et al.
Therapeutic Drug Monitoring|August 20, 2019
Excretion of Antipsychotics Into the Amniotic Fluid, Umbilical Cord Blood, and Breast Milk: A Systematic Critical Review and Combined AnalysisGeorgios Schoretsanitis, Andreas A Westin, Kristina M Deligiannidis, et al.
Archives of Women'S Mental Health|August 18, 2018
Antidepressants in breast milk; comparative analysis of excretion ratiosGeorgios Schoretsanitis, Marc Augustin, Helena Saßmannshausen, et al.
Schizophrenia Research|June 12, 2019
Effect of fluvoxamine augmentation and smoking on clozapine serum concentrationsMarc Augustin, Georgios Schoretsanitis, Philippe Pfeifer, et al.
The Journal of Clinical Psychiatry|September 8, 2018
Differences in Duloxetine Dosing Strategies in Smoking and Nonsmoking Patients: Therapeutic Drug Monitoring Uncovers the Impact on Drug MetabolismMarc Augustin, Georgios Schoretsanitis, Christoph Hiemke, et al.
Pageof 10